Mark J. Brooks, Managing Director, leads investments in the healthcare services, medical device and drug development industries for Scale Venture Partners. Mark is ScaleVP's representative on the Board of Directors for Alimera Sciences (NASDAQ: ALIM), In-Patient Consultants Management, Inc., LivHome, Inc., National Healing Holding Corporation, Oraya Therapeutics and Spinal Kinetics, Inc. He is responsible for the firm's successful investments in Cardiac Pathways, Cygnal Integrated Products, Rita Medical and U.S. Healthworks.

Mark joined the Investment Team in 1995. Prior to joining ScaleVP, he was a Senior Associate for Mercer Management Consulting, where he led projects in the healthcare and telecommunications sectors. Prior to Mercer, he served as a Loan Officer in the Media Group of Manufacturers Hanover Trust Company, where he provided LBO and acquisition capital to cable, entertainment and publishing companies.

Mark holds a B.A. in Economics from Dartmouth College and an M.B.A. in Finance and Entrepreneurial Management from The Wharton School at the University of Pennsylvania.

Mark's Portfolio

Alimera Sciences
Cardiac Pathways
Cygnal Integrated Products
Esurg.com
IPC The Hospitalist Company
LivHome
Manorhouse Retirement Centers
National Healing
Oraya Therapeutics
RITA Medical Systems
Spinal Kinetics
Sylantro Systems 
U.S. HealthWorks

Mark's Podcasts